TENNOR THERAP-B (6872.HK) — Stock Score Summary

TENNOR THERAP-B (6872.HK) has a MoatMap StockRank of 2/100 based on Quality (28/100), Value (22/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL. TENNOR THERAP-B is a pre-revenue biotechnology company that lacks the established cash flows, high ROIC, and quality compounder characteristics required by our investment framework.

Tennor Therapeutics Limited is a clinical-stage biopharmaceutical company focused on discovering and developing novel, dual-acting therapeutics for infectious diseases. The company's proprietary drug discovery platform targets unmet medical needs in gastrointestinal infections and drug-resistant bacterial pathogens. Its competitive position is anchored by a robust pipeline of first-in-class and best-in-class small molecule candidates with global intellectual property rights.

Key Financial Metrics

Price$31.62
Market Cap$1.4B
Price/Book52.54
Return on Invested Capital-80.3%
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-697K

TENNOR THERAP-B operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is TENNOR THERAP-B’s (6872.HK) StockRank?
MoatMap’s StockRank for TENNOR THERAP-B (6872.HK) is 2/100, with a Strong Sell signal. It is a composite of Quality (28), Value (22), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does TENNOR THERAP-B have an economic moat?
TENNOR THERAP-B (6872.HK) has a Quality factor score of 28/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is TENNOR THERAP-B a buy, hold, or sell?
MoatMap’s current signal for TENNOR THERAP-B (6872.HK) is Strong Sell, based on a StockRank of 2/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is TENNOR THERAP-B in?
TENNOR THERAP-B (6872.HK) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks6872.HK deep dive reportAI ChampionsHow we score stocksSense-check another stock